Skip to content

LeMaitre Vascular LMAT Price / earnings

Price / earnings at other companies

ITG
Integer HoldingsITGR
21.4×-32.6×
Merit Medical Systems logo
Merit Medical SystemsMMSI
29.4×-21.5×
Haemonetics logo
HaemoneticsHAE
21.4×-8.8×
Abbott logo
AbbottABT
28.4×+11.4×
Baxter International logo
Baxter InternationalBAX
179.4×+172×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
39.3×-4.6×

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Calculated from LeMaitre Vascular’s reported figures.

Based on the most recent quarter.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's price / earnings?
LeMaitre Vascular (LMAT) reported price / earnings of 39.8× in Q1 2026.
How has LeMaitre Vascular's price / earnings changed year-over-year?
LeMaitre Vascular's price / earnings decreased by 4.9% year-over-year, from 41.9× to 39.8×.
What is the long-term trend for LeMaitre Vascular's price / earnings?
Over 5 years (2020 to 2025), LeMaitre Vascular's price / earnings has grown at a -5.2% compound annual growth rate (CAGR), from 41.7× to 31.9×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.